Related Experiment Video
Updated: Jul 17, 2026

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
Analysis and prediction of pathological risk factors for lung cancer by plasma metabolomics
Zixu Liu1, Ling Wang2, Shugeng Gao3
1Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Hebei Cancer Hospital, Langfang, PR China.
Background:
Common pathological risk factors for lung cancer include lymphovascular invasion (LVI), spread through air space (STAS) and perineural invasion (PNI). They are important factors that cause tumor recurrence after surgery, and also reference indices to determine the scope of surgical resection. At present, there is a lack of effective methods for preoperative judgment of the type and number of risk factors.
Methods:
In this study, lung cancer was divided into three groups according to the number of pathological risk factors. Metabolites that can identify the number of risk factors were selected. Their differential diagnosis ability was evaluated by the area under ROC curve, sensitivity, specificity, Cohen's Kappa and F1 index.
Results:
Among 160 lung cancer, 119 had no risk factors, 24 had one risk factor, and 17 had two or more risk factors. After the comparisons of these three groups with healthy volunteers, five metabolites with differential diagnosis ability were screened out. The indicators to assess their discriminative ability were satisfactory.
Conclusion:
Metabolites discovered by metabolomics can identify the number of pathological risk factors associated with lung cancer. It is helpful to determine the extent of lung resection before surgery.
More Related Videos
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Related Concept Videos
Cancer Prevention
Some...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Statistical Methods for Analyzing Epidemiological Data
Cancer Survival Analysis